These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

475 related articles for article (PubMed ID: 33146392)

  • 21. Rates and trends in stage-specific prostate cancer incidence by age and race/ethnicity, 2000-2017.
    Cao Y; Zhang W; Li Y; Fu J; Li H; Li X; Gao X; Zhang K; Liu S
    Prostate; 2021 Oct; 81(14):1071-1077. PubMed ID: 34320230
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anal cancer incidence and mortality in Puerto Rico.
    Colón-López V; Ortiz AP; Soto-Salgado M; Torres-Cintrón M; Mercado-Acosta JJ; Suárez E
    P R Health Sci J; 2013 Jun; 32(2):76-81. PubMed ID: 23781623
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Racial and ethnic disparities in prostate cancer screening following the 2018 US Preventive Services Task Force recommendation statement.
    VanderVeer-Harris N; Zippi ZD; Patel DP; Manoharan M; Caso JR; Vaidean GD
    J Med Screen; 2024 Apr; ():9691413241248052. PubMed ID: 38646707
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Racial/Ethnic Disparities in Prostate Cancer Incidence, Distant Stage Diagnosis, and Mortality by U.S. Census Region and Age Group, 2012-2015.
    Iyengar S; Hall IJ; Sabatino SA
    Cancer Epidemiol Biomarkers Prev; 2020 Jul; 29(7):1357-1364. PubMed ID: 32303533
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Abrogation of survival disparity between Black and White individuals after the USPSTF's 2012 prostate-specific antigen-based prostate cancer screening recommendation.
    Kim IE; Jang TL; Kim S; Modi PK; Singer EA; Elsamra SE; Kim IY
    Cancer; 2020 Dec; 126(23):5114-5123. PubMed ID: 32888321
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prostate-specific antigen testing rates in high-risk populations: results from the All of Us Research Program.
    Morley F; Iyer HS; Tamimi RM; Nanus DM; Rebbeck TR; Kensler KH
    Cancer Causes Control; 2024 Mar; 35(3):509-521. PubMed ID: 37878135
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Robot-Assisted Surgery and Racial and Ethnic Disparities in Post-Prostatectomy Outcomes Among Prostate Cancer Patients.
    Mao J; Genkinger JM; Rundle AG; Wright JD; Schymura MJ; Insaf TZ; Hu JC; Tehranifar P
    Ann Surg Oncol; 2024 Feb; 31(2):1373-1383. PubMed ID: 37880515
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prostate-specific antigen testing after the US Preventive Services Task Force recommendation: a population-based analysis of electronic health data.
    Frendl DM; Epstein MM; Fouayzi H; Krajenta R; Rybicki BA; Sokoloff MH
    Cancer Causes Control; 2020 Sep; 31(9):861-867. PubMed ID: 32556947
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Racial/ethnic disparities in early-onset colorectal cancer: implications for a racial/ethnic-specific screening strategy.
    Acuna-Villaorduna AR; Lin J; Kim M; Goel S
    Cancer Med; 2021 Mar; 10(6):2080-2087. PubMed ID: 33641251
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Trends in Prostate Cancer Incidence Rates and Prevalence of Prostate Specific Antigen Screening by Socioeconomic Status and Regions in the United States, 2004 to 2013.
    Houston KA; King J; Li J; Jemal A
    J Urol; 2018 Mar; 199(3):676-682. PubMed ID: 28965781
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Declines in Vaccine-Type Human Papillomavirus Prevalence in Females Across Racial/Ethnic Groups: Data From a National Survey.
    McClung NM; Lewis RM; Gargano JW; Querec T; Unger ER; Markowitz LE
    J Adolesc Health; 2019 Dec; 65(6):715-722. PubMed ID: 31515134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prostate cancer incidence among American Indian and Alaska Native men, US, 1999-2004.
    Henderson JA; Espey DK; Jim MA; German RR; Shaw KM; Hoffman RM
    Cancer; 2008 Sep; 113(5 Suppl):1203-12. PubMed ID: 18720376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Racial disparities in colorectal cancer outcomes and access to care: a multi-cohort analysis.
    Riviere P; Morgan KM; Deshler LN; Demb J; Mehtsun WT; Martinez ME; Gupta S; Banegas M; Murphy JD; Rose BS
    Front Public Health; 2024; 12():1414361. PubMed ID: 38962767
    [TBL] [Abstract][Full Text] [Related]  

  • 34. PSA screening, prostate biopsy, and treatment of prostate cancer in the years surrounding the USPSTF recommendation against prostate cancer screening.
    Kearns JT; Holt SK; Wright JL; Lin DW; Lange PH; Gore JL
    Cancer; 2018 Jul; 124(13):2733-2739. PubMed ID: 29781117
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Growing Burden of Endometrial Cancer: A Major Racial Disparity Affecting Black Women.
    Cote ML; Ruterbusch JJ; Olson SH; Lu K; Ali-Fehmi R
    Cancer Epidemiol Biomarkers Prev; 2015 Sep; 24(9):1407-15. PubMed ID: 26290568
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Screening for Prostate Cancer: US Preventive Services Task Force Recommendation Statement.
    ; Grossman DC; Curry SJ; Owens DK; Bibbins-Domingo K; Caughey AB; Davidson KW; Doubeni CA; Ebell M; Epling JW; Kemper AR; Krist AH; Kubik M; Landefeld CS; Mangione CM; Silverstein M; Simon MA; Siu AL; Tseng CW
    JAMA; 2018 May; 319(18):1901-1913. PubMed ID: 29801017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Racial differences in patient-reported outcomes among men treated with radical prostatectomy for prostate cancer.
    Koelker M; Labban M; Frego N; Ye J; Lipsitz SR; Hubbell HT; Edelen M; Steele G; Salinas K; Meyer CP; Makanjuola J; Moore CM; Cole AP; Kibel AS; Trinh QD
    Prostate; 2024 Jan; 84(1):47-55. PubMed ID: 37710385
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the USPSTF Grade D Recommendation Against Prostate-Specific Antigen Screening With Prostate Cancer-Specific Mortality.
    Burgess L; Aldrighetti CM; Ghosh A; Niemierko A; Chino F; Huynh MJ; Efstathiou JA; Kamran SC
    JAMA Netw Open; 2022 May; 5(5):e2211869. PubMed ID: 35576008
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Decreasing Incidence of Estrogen Receptor-Negative Breast Cancer in the United States: Trends by Race and Region.
    Davis Lynn BC; Chernyavskiy P; Gierach GL; Rosenberg PS
    J Natl Cancer Inst; 2022 Feb; 114(2):263-270. PubMed ID: 34508608
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey.
    Ross LE; Berkowitz Z; Ekwueme DU
    Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):636-44. PubMed ID: 18349281
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.